But the day after FDA upscheduled these hydrocodone drugs, like OxyContin, the next day, inexplicably, the FDA Director allowed the sale of Zohydro, a new, extremely potent, 10 times OxyContin's strength, is to be released with no abuse-deterrent characteristics.
Rogers criticizes the FDA's decision to allow Zohydro's sale despite its potency and lack of abuse deterrents.
Share
More from Hal Rogers
I thank the chairwoman for yielding. Mr. Speaker, as chairman of the Subcommittee on Commerce, Justice, Science, and Related Agencies, I rise in support of the appropriations act that we are considering today. The fiscal situation facing…
It was very clear, Mr. Chairman, to people on two continents that this Kentucky delegation was serious about its constituent's well being and her need to be home.
I claim time in support of the amendments, and I yield myself such time as I may consume. This amendments en bloc contains a number of good proposals by both sides of the aisle. I want to highlight just a few. It includes language offered…
Other voices in this conversation
